Universitätsmedizin Berlin has found that a single dose of the Imvanex vaccine provides protection against mpox with 84% ...

One dose of the Jynneos vaccine was 58% effective against mpox infection overall and 84% in people without HIV, but only 35% ...

In his first term, President Donald Trump launched a bold and successful initiative against HIV. This time around, the ...

The bulk of the terminated grants have to do with vaccine hesitancy, HIV, Black or Latino communities and/or sex, gender and ...

Increasing HPV vaccination rates could help decrease the number of cancer cases “attributable to HIV,” according to data from a study presented at the Conference on Retroviruses and Opportunistic ...

Most Americans do not feel at risk for most IDs because scientific developments have mitigated their impact, said Kelley.

Universitätsmedizin Berlin has found that a single dose of the Imvanex vaccine provides protection against Mpox with 84% ...

One avenue for new vaccine development is mucosal vaccines. In theory, dosing the vaccine directly into the respiratory tract ...

A groundbreaking project to study potential HIV vaccines in several African countries has been derailed by abrupt US funding cuts. As a result, several promising vaccine candidates might not be tested ...

A vaccine's ability to generate long-lasting, high-affinity antibodies hinges on a delicate balance. Upon exposure to a vaccine or pathogen, B cells scramble to refine their defenses, rapidly mutating ...

It is important that the Global South and Global North continue to work together, finding solutions to these diseases that ...